Aldawaa profit leaps 25% to SAR 95.3M in Q1 2024

Aldawaa profit leaps 25% to SAR 95.3M in Q1 2024

29/04/2024 Argaam Exclusive

View other reports

Aldawaa Medical Services Co. (DMSCO) reported a net profit of SAR 95.3 million for Q1 2024, leaping 25% from SAR 76.3 million in the same period last year.



Current Quarter Comparison (M)

Compared With The
Item Q1 2023 Q1 2024 Change‬
Revenues 1,407.59 1,516.42 7.7 %
Gross Income 534.98 564.42 5.5 %
Operating Income 116.00 130.49 12.5 %
Net Income 76.25 95.33 25.0 %
Average Shares 85.00 85.00 -
EPS (Riyals) 0.90 1.12 25.0 %

Revenues in the first quarter of 2024 grew 7.7% year-on-year (YoY) to SAR 108.8 million, due to the increase in sales activities across all channels.

 

Gross profit increased by 5.5% YoY to SAR 29.4 million, and operating profit grew by 13.6% YoY on controlling expenses.

 

Sequentially, Q1 2024 net profit was up 3.2% from SAR 92.35 million in Q4 2023, mainly fueled by a 4% rise quarter-on-quarter in revenues to SAR 58.3 million.

 

Total shareholders’ equity, no minority interest, rose to SAR 1.29 billion as of March 31, 2024, from SAR 1.07 billion a year earlier.



Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 1,176.38 - 446.33 - 91.48 -
Q2 2020 1,303.84 - 530.76 - 131.66 -
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 1,209.72 2.8 % 451.96 1.3 % 74.35 (18.7 %)
Q2 2021 1,266.77 (2.8 %) 457.98 (13.7 %) 66.91 (49.2 %)
Q3 2021 1,259.56 - 451.39 - 50.81 -
Q4 2021 1,298.34 - 533.08 - 75.82 -
Q1 2022 1,294.82 7.0 % 494.18 9.3 % 70.71 (4.9 %)
Q2 2022 1,310.19 3.4 % 506.79 10.7 % 90.55 35.3 %
Q3 2022 1,308.93 3.9 % 484.94 7.4 % 82.69 62.7 %
Q4 2022 1,458.30 12.3 % 533.69 0.1 % 130.39 72.0 %
Q1 2023 1,407.59 8.7 % 534.98 8.3 % 116.00 64.0 %
Q2 2023 1,436.74 9.7 % 525.64 3.7 % 126.28 39.5 %
Q3 2023 1,438.95 9.9 % 520.91 7.4 % 104.60 26.5 %
Q4 2023 1,458.09 0.0 % 525.09 (1.6 %) 140.39 7.7 %
Q1 2024 1,516.42 7.7 % 564.42 5.5 % 130.49 12.5 %


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 23.11 - 0.29 (52.93) 76.04 0.95
Q2 2020 55.35 - 0.69 (61.91) 117.26 1.47
Q3 2020 - - - - - -
Q4 2020 - - - - - -
Q1 2021 78.84 241.2 % 0.99 21.49 57.35 0.72
Q2 2021 52.94 (4.4 %) 0.62 5.84 47.10 0.55
Q3 2021 38.29 - 0.45 9.85 28.44 0.33
Q4 2021 69.08 - 0.81 26.24 42.84 0.50
Q1 2022 87.11 10.5 % 1.02 38.14 48.97 0.58
Q2 2022 80.67 52.4 % 0.95 14.47 66.21 0.78
Q3 2022 48.15 25.7 % 0.57 (1.08) 49.24 0.58
Q4 2022 89.51 29.6 % 1.05 7.74 81.77 0.96
Q1 2023 76.25 (12.5 %) 0.90 - 76.25 0.90
Q2 2023 89.33 10.7 % 1.05 - 89.33 1.05
Q3 2023 71.28 48.0 % 0.84 - 71.28 0.84
Q4 2023 92.35 3.2 % 1.09 - 92.35 1.09
Q1 2024 95.33 25.0 % 1.12 - 95.33 1.12

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 37.63 % 11.95 % 3.49 %
Q1 2022 37.83 % 12.05 % 3.27 %
Q2 2022 38.46 % 12.59 % 3.61 %
Q3 2022 38.74 % 13.20 % 3.98 %
Q4 2022 37.59 % 13.57 % 4.58 %
Q1 2023 37.56 % 13.96 % 4.99 %
Q2 2023 37.05 % 14.35 % 5.29 %
Q3 2023 36.84 % 14.47 % 5.55 %
Q4 2023 36.69 % 14.82 % 5.73 %
Q1 2024 36.51 % 14.86 % 5.95 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 79.85 - - -
Q2 2020 79.85 - - -
Q3 2020 - - - -
Q4 2020 - - - -
Q1 2021 79.85 - - 14.62
Q2 2021 85.00 - - 14.74
Q3 2021 85.00 - - 12.46
Q4 2021 85.00 2.81 2.07 11.64
Q1 2022 85.00 2.91 1.97 12.61
Q2 2022 85.00 3.24 2.19 12.78
Q3 2022 85.00 3.35 2.44 12.07
Q4 2022 85.00 3.59 2.90 12.88
Q1 2023 85.00 3.47 3.22 12.67
Q2 2023 85.00 3.57 3.49 14.74
Q3 2023 85.00 3.84 3.75 14.17
Q4 2023 85.00 3.87 3.87 15.45
Q1 2024 85.00 4.10 4.10 15.28

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 25.59 37.84 5.91
Q2 2022 20.70 30.54 5.24
Q3 2022 23.77 32.69 6.61
Q4 2022 20.01 24.83 5.58
Q1 2023 23.08 24.87 6.31
Q2 2023 27.61 28.23 6.68
Q3 2023 24.77 25.37 6.71
Q4 2023 27.32 27.32 6.85
Q1 2024 22.72 22.72 6.09

Business Segments (Million)

Compared With The
Period Retail Sales Wholesale Logistic Services
Q1 2021 1,169.76 39.96 -
Q2 2021 1,234.85 31.92 -
Q3 2021 1,224.38 35.18 -
Q4 2021 1,257.00 41.34 -
Q1 2022 1,260.57 34.25 -
Q2 2022 1,268.35 41.84 -
Q3 2022 1,261.85 47.08 -
Q4 2022 1,376.54 81.76 -
Q1 2023 1,341.18 66.41 -
Q2 2023 1,366.98 69.76 -
Q3 2023 1,352.17 86.77 -
Q4 2023 1,382.63 58.37 17.09
Q1 2024 1,441.98 74.44 -

Analysts Estimates (Million)

Item Q1 2024 (e) Q1 2024 (a) Change‬
Average 96.20 95.33 (0.9 %)

Estimates vs Actual (Million)

Item Q1 2024 (e) Q1 2024 (a) Change
OSOOL AND BAKHEET 94.30 95.33 1.1 %
United Securities Company 94.00 95.33 1.4 %
Hermes 87.00 95.33 9.6 %
SNB Capital 83.70 95.33 13.9 %
Riyad Capital 122.00 95.33 (21.9) %

Current
Market Cap (M Riyal) 6,808.50
Enterprise Value (EV) (M) 7,366.97
Shares Outstanding ((M)) 85.00
EPS ( Riyal) (TTM) 4.22
Book Value (BV) ( Riyal) 16.65
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 18.98
P/E (TTM) 18.98
Price/book 4.81
Return on Average Assets (%) (TTM) 7.5
Return on Average Equity (%) (TTM) 27.4

Share Price

Aldawaa Medical Services Co. (ALDAWAA)


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.